LTR PHARMA LIMITED (LTP)
AI Coverage Rating: Active
ASX AI Signals has generated 4 signal for LTP during the last 90 days,
indicating active trading activity and ongoing AI monitoring
Latest LTP Signals |
| 09/06/2026 | BUY |
| 08/06/2026 | BUY |
| 07/06/2026 | BUY |
LTP Share Price |
| Current Price | $0.575 |
| 52 Week High | $0.735 |
| 52 Week Low: | $0.285 |
| Trading at (% of 52 Week High) | 78.23% |
Volume
154312
20 Day Avg
739390
Relative Volume
20.9%
Business Overview
LTR Pharma Limited (ASX: LTP) is an Australian pharmaceutical company specializing in the development and commercialization of novel medicines for the treatment of respiratory and inflammatory diseases. The company focuses on advancing its product pipeline through research, clinical trials, and strategic partnerships.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The BUY signal for LTR PHARMA LIMITED at the current price of 0.4650 is supported by positive momentum indicators and potential sector growth. However, moderate liquidity and volatility concerns temper the confidence level.
Latest LTR PHARMA LIMITED(LTP) News
17 Mar 2026, 08:00 AM
Aptar’s Intranasal Delivery System Utilized in Phase II Clinical Study of SPONTAN® Nasal Spray
Supporting advancement of complex intranasal therapies through clinical development
CRYSTAL LAKE, Ill., March 16, 2026--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dos
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial